Aptagen, LLC
RNA
Dopamine
Small Organic
1.6 µM (reported value)
Column Buffer: 50 mM Tris-HCl (pH 7.4), 5 mM MgCl2, and 0.5 M or 0.15 M NaCl
RT°C
NA If the oligo is a known aptamer sequence: For binding studies, perform a refolding protocol to ensure proper function (i.e. binding to antigen or target). Refer to the aptamer reference source for the appropriate refolding parameters and binding conditions. Note: it is unknown whether aptamer functions properly without refolding.
Dopamine (dopa2/c.1) (ID# 95)
5'rGprGprGp rAprAprUp rUprCprCp rGprCprGp rUprGprUp rGprCprGp rCprCprGp rCprGprGp rAprAprGp rAprCprGp rUprUprGp rGprAprAp rGprGprAp rUprAprGp rAprUprAp rCprCprUp rAprCprAp rAprCprGp rGprGprGp rAprAprUp rAprUprAp rGprAprGp rGprCprCp rAprGprCp rAprCprAp rUprAprGp rUprGprAp rGprGprCp rCprCprUp rCprCprUp rCprCprCp3'
103
30112.25 g/mole
921600 L/(mole·cm)
58.06%
1.09
32.67
Note: Information on this aptamer oligo was obtained from the literature and hasn't been validated by Aptagen.
Mannironi, C., et al. "In Vitro Selection of Dopamine RNA Ligands." Biochemistry, 36 (1997): 9726-973.
Have your aptamer oligo synthesized ORDER NOW
We are always looking for ways to improve. Please tell us what you think.